TP53 and cancer: These results align with emerging evidence that p53 restrains exaggerated injury responses in other epithelial tissues100,110,111 and support a model in which p53 and KRAS co-modulate both cell-intrinsic programs and tissue-scale dynamics to govern cancer risk.